Casdin Capital, LLC Q4 2020 Filing
Filed February 16, 2021
Portfolio Value
$3.4T
Holdings
51
Report Date
Q4 2020
Filing Type
13F-HR
All Holdings (51 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NVTA1EURINVITAE CORP | 12,298,038 | $514.2B | 15.23% | |
| 2 | BLFSBIOLIFE SOLUTIONS INC | 7,440,107 | $296.8B | 8.79% | |
| 3 | FATEFATE THERAPEUTICS INC | 3,050,000 | $277.3B | 8.22% | |
| 4 | EXASEXACT SCIENCES CORP | 1,485,149 | $196.8B | 5.83% | |
| 5 | 2L9BLUEPRINT MEDICINES CORP | 1,550,000 | $173.8B | 5.15% | |
| 6 | RLAYRELAY THERAPEUTICS INC | 3,808,894 | $158.3B | 4.69% | |
| 7 | TWSTTWIST BIOSCIENCE CORP | 1,000,000 | $141.3B | 4.19% | |
| 8 | PACBPACIFIC BIOSCIENCES CALIF IN | 5,000,000 | $129.7B | 3.84% | |
| 9 | DNLIDENALI THERAPEUTICS INC | 1,310,000 | $109.7B | 3.25% | |
| 10 | AGIOAGIOS PHARMACEUTICALS INC | 2,375,000 | $102.9B | 3.05% | |
| 11 | ALNYALNYLAM PHARMACEUTICALS INC | 780,000 | $101.4B | 3.00% | |
| 12 | CDXSCODEXIS INC | 4,330,000 | $94.5B | 2.80% | |
| 13 | SRPTSAREPTA THERAPEUTICS INC | 530,000 | $90.4B | 2.68% | |
| 14 | CDNACAREDX INC | 1,193,335 | $86.5B | 2.56% | |
| 15 | RVMDREVOLUTION MEDICINES INC | 1,634,535 | $64.7B | 1.92% | |
| 16 | —CONSTELLATION PHARMCETICLS I | 1,785,000 | $51.4B | 1.52% | |
| 17 | GBIOGBXGENERATION BIO CO | 1,611,214 | $45.7B | 1.35% | |
| 18 | DMTKQDERMTECH INC | 1,370,000 | $44.4B | 1.32% | |
| 19 | BNRBURNING ROCK BIOTECH LTD | 1,922,150 | $44.4B | 1.32% | |
| 20 | ADPTADAPTIVE BIOTECHNOLOGIES COR | 713,125 | $42.2B | 1.25% | |
| 21 | CRSPCRISPR THERAPEUTICS AG | 266,430 | $40.8B | 1.21% | |
| 22 | —BLUEBIRD BIO INC | 915,000 | $39.6B | 1.17% | |
| 23 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 3,650,000 | $39.6B | 1.17% | |
| 24 | ONCBEIGENE LTD | 150,000 | $38.8B | 1.15% | |
| 25 | BEAMBEAM THERAPEUTICS INC | 460,000 | $37.6B | 1.11% | |
| 26 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 860,000 | $37.2B | 1.10% | Call |
| 27 | FDMT4D MOLECULAR THERAPEUTICS IN | 780,555 | $32.4B | 0.96% | |
| 28 | —MAGENTA THERAPEUTICS INC | 3,346,034 | $26.2B | 0.78% | |
| 29 | ZLABZAI LAB LTD | 190,000 | $25.7B | 0.76% | |
| 30 | IOVAIOVANCE BIOTHERAPEUTICS INC | 550,000 | $25.5B | 0.76% | |
| 31 | ALECALECTOR INC | 1,650,000 | $25.0B | 0.74% | |
| 32 | ALLOALLOGENE THERAPEUTICS INC | 945,000 | $23.9B | 0.71% | |
| 33 | MASS908 DEVICES INC | 406,502 | $23.1B | 0.69% | |
| 34 | TSHATAYSHA GENE THERAPIES INC | 820,440 | $21.8B | 0.65% | |
| 35 | ORICORIC PHARMACEUTICALS INC | 601,515 | $20.4B | 0.60% | |
| 36 | BLIUSDBERKELEY LTS INC | 200,000 | $17.9B | 0.53% | |
| 37 | KRON1USDKRONOS BIO INC | 583,436 | $17.4B | 0.52% | |
| 38 | GBYSANGAMO THERAPEUTICS INC | 1,080,000 | $16.9B | 0.50% | |
| 39 | FULCFULCRUM THERAPEUTICS INC | 1,241,176 | $14.5B | 0.43% | |
| 40 | AMRSEURAMYRIS INC | 2,000,000 | $12.3B | 0.37% | Call |
| 41 | SNDXSYNDAX PHARMACEUTICALS INC | 450,000 | $10.0B | 0.30% | |
| 42 | BDTXBLACK DIAMOND THERAPEUTICS I | 289,395 | $9.3B | 0.27% | |
| 43 | —TURNING POINT THERAPEUTICS I | 75,000 | $9.1B | 0.27% | |
| 44 | SEERSEER INC | 150,000 | $8.4B | 0.25% | |
| 45 | ABCLABCELLERA BIOLOGICS INC | 200,000 | $8.0B | 0.24% | |
| 46 | DYNDYNE THERAPEUTICS INC | 370,000 | $7.8B | 0.23% | |
| 47 | STOKSTOKE THERAPEUTICS INC | 120,000 | $7.4B | 0.22% | |
| 48 | FHTXFOGHORN THERAPEUTICS INC | 216,216 | $4.4B | 0.13% | |
| 49 | BMY-RBRISTOL-MYERS SQUIBB CO | 6,250,000 | $4.3B | 0.13% | |
| 50 | —CODIAK BIOSCIENCES INC | 76,688 | $2.5B | 0.07% | |
| 51 | CCCCC4 THERAPEUTICS INC | 40,000 | $1.3B | 0.04% |